Exact Mass: 233.1346

Exact Mass Matches: 233.1346

Found 164 metabolites which its exact mass value is equals to given mass value 233.1346, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Methylphenidate

Mallinckrodt brand OF methylphenidate hydrochloride

C14H19NO2 (233.1416)


Methylphenidate is only found in individuals that have used or taken this drug. It is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine. [PubChem]Methylphenidate blocks dopamine uptake in central adrenergic neurons by blocking dopamine transport or carrier proteins. Methylphenidate acts at the brain stem arousal system and the cerebral cortex and causes increased sympathomimetic activity in the central nervous system. Alteration of serotonergic pathways via changes in dopamine transport may result. N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators

   

Normeperidine

Ethyl 4-phenylpiperidine-4-carboxylic acid

C14H19NO2 (233.1416)


Pethidine (INN) or meperidine hydrochloride (USAN) (commonly referred to as Demerol in the US but also referred to as: isonipecaine; lidol; pethanol; piridosal; Algil; Alodan; Centralgin; Dispadol; Dolantin; Mialgin (in Indonesia); Petidin Dolargan (in Poland); Dolestine; Dolosal; Dolsin; Mefedina) is a fast-acting opioid analgesic drug. Pethidine is quickly hydrolysed in the liver to pethidinic acid and is also demethylated to norpethidine, which has half the analgesic activity of pethidine but a longer elimination half-life (8-12 hours); accumulating with regular administration, or in renal failure. Norpethidine is toxic and has convulsant and hallucinogenic effects. The toxic effects mediated by the metabolites cannot be countered with opioid receptor antagonists such as naloxone or naltrexone and are probably primarily due to norpethidines anticholinergic activity probably due to its structural similarity to atropine though its pharmacology has not been thoroughly explored. The neurotoxicity of pethidines metabolites is a unique feature of pethidine compared to other opioids. Pethidines metabolites are further conjugated with glucuronic acid and excreted into the urine. D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D004791 - Enzyme Inhibitors

   

Lysinoalanine

2-amino-6-[(2-amino-2-carboxyethyl)amino]hexanoic acid

C9H19N3O4 (233.1375)


Nephrotoxic food contaminan

   

Thalictroidine

1-(4-hydroxyphenyl)-2-(1-methylpiperidin-2-yl)ethan-1-one

C14H19NO2 (233.1416)


Thalictroidine is found in coffee and coffee products. Thalictroidine is an alkaloid from the rhizomes of Caulophyllum thalictroides (blue cohosh Alkaloid from the rhizomes of Caulophyllum thalictroides (blue cohosh). Thalictroidine is found in coffee and coffee products.

   

Seryllysine

(2S)-6-Amino-2-{[(2S)-2-amino-1,3-dihydroxypropylidene]amino}hexanoate

C9H19N3O4 (233.1375)


Seryllysine is a dipeptide composed of serine and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Lysylserine

(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanoic acid

C9H19N3O4 (233.1375)


Lysylserine is a dipeptide composed of lysine and serine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Hydroxypropionylcarnitine

(3S)-3-[(3-hydroxypropanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C10H19NO5 (233.1263)


Hydroxypropionylcarnitine is an acylcarnitine. More specifically, it is an hydroxypropionoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Hydroxypropionylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine hydroxypropionylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. It is also decreased in the urine of individuals with obesity (PMID: 26910390) and systolic heart failure (PMID: 26010610). Hydroxypropionylcarnitine can also be found incerebrospinal fluid. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. A human metabolite taken as a putative food compound of mammalian origin [HMDB]

   

Dexmethylphenidate

methyl (2R)-2-phenyl-2-[(2R)-piperidin-2-yl]acetate

C14H19NO2 (233.1416)


Dexmethylphenidate is only found in individuals that have used or taken this drug. It is the dextrorotary form of methylphenidate. It is used for treatment of Attention Deficit Hyperactivity Disorder (ADHD). Methylphenidate blocks dopamine uptake in central adrenergic neurons by blocking dopamine transport or carrier proteins. Methylphenidate acts at the brain stem arousal system and the cerebral cortex and causes increased sympathomimetic activity in the central nervous system.Methylphenidate is a catecholamine reuptake inhibitor that indirectly increases catecholaminergic neurotransmission by inhibiting the dopamine transporter (DAT) and norepinephrine transporter (NET), which are responsible for clearing catecholamines from the synapse, particularly in the striatum and meso-limbic system. N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators

   

2-Phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide

(4,4,5,5-tetramethyl-3-oxido-2-phenyl-4,5-dihydro-1H-imidazol-3-ium-1-yl)oxidanyl

C13H17N2O2 (233.129)


D000975 - Antioxidants > D016166 - Free Radical Scavengers D020011 - Protective Agents > D000975 - Antioxidants

   

4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid

4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid

C10H19NO5 (233.1263)


D002491 - Central Nervous System Agents > D018697 - Nootropic Agents

   

Norketobemidone

1-[4-(3-hydroxyphenyl)piperidin-4-yl]propan-1-one

C14H19NO2 (233.1416)


   

Piperoxan

1-[(2,3-dihydro-1,4-benzodioxin-2-yl)methyl]piperidine

C14H19NO2 (233.1416)


   
   
   

Paniculidine B

Paniculidine B

C14H19NO2 (233.1416)


   

metolachlor morpholinone

4-(2-Ethyl-6-methylphenyl)-5-methylmorpholin-3-one

C14H19NO2 (233.1416)


A member of the class of morpholines that is morpholin-3-one substituted by a 2-ethyl-6-methylphenyl group at position 4 and a methyl group at position 5. It is a metabolite of metolachlor. CONFIDENCE standard compound; EAWAG_UCHEM_ID 67

   

4-Methoxy-alpha-pyrrolidinopropiophenone

4-Methoxy-alpha-pyrrolidinopropiophenone

C14H19NO2 (233.1416)


   

1-(4-methylphenyl)-3-morpholin-4-ylpropan-1-one

1-(4-methylphenyl)-3-morpholin-4-ylpropan-1-one

C14H19NO2 (233.1416)


   

2-(3-methoxyphenyl)-2-(methylamino)cyclohexanone

2-(3-methoxyphenyl)-2-(methylamino)cyclohexanone

C14H19NO2 (233.1416)


   

Methoxyketamine

Methoxyketamine

C14H19NO2 (233.1416)


   
   

1,2-Epoxy-2-methyl-4-(N-methyltyraminyl)-3-butene|4-(2-N-methyltyraminyl)-(Z)-1,2-epoxy-2-methylbut-3-ene

1,2-Epoxy-2-methyl-4-(N-methyltyraminyl)-3-butene|4-(2-N-methyltyraminyl)-(Z)-1,2-epoxy-2-methylbut-3-ene

C14H19NO2 (233.1416)


   

Me glycoside,N-Ac,4-mesyl-beta-D-Pyranose-3-Amino-3,6-dideoxygalactose

Me glycoside,N-Ac,4-mesyl-beta-D-Pyranose-3-Amino-3,6-dideoxygalactose

C10H19NO5 (233.1263)


   

3-(5-imidazolyl)propionylhistamine

3-(5-imidazolyl)propionylhistamine

C11H15N5O (233.1277)


   

(E)-N-(4-methoxyphenethyl)-2-methylbut-2-enamide

(E)-N-(4-methoxyphenethyl)-2-methylbut-2-enamide

C14H19NO2 (233.1416)


   
   
   

N-[2-(4-Methoxyphenyl)ethyl]-3-methylbut-2-enamide

N-[2-(4-Methoxyphenyl)ethyl]-3-methylbut-2-enamide

C14H19NO2 (233.1416)


   

SCHEMBL7524756

SCHEMBL7524756

C10H19NO5 (233.1263)


   

Ganoderpurine

Ganoderpurine

C11H15N5O (233.1277)


   

Et glycoside,N-Ac-alpha-D-Pyranose-2-Amino-2,3-dideoxy-ribo-hexopyranose

Et glycoside,N-Ac-alpha-D-Pyranose-2-Amino-2,3-dideoxy-ribo-hexopyranose

C10H19NO5 (233.1263)


   

Metolachlor-Morpholinone

4-(2-Ethyl-6-methylphenyl)-5-methylmorpholin-3-one

C14H19NO2 (233.1416)


CONFIDENCE standard compound; INTERNAL_ID 2059

   

Ritalin

methylphenidate

C14H19NO2 (233.1416)


N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators

   

normeperidine

normeperidine

C14H19NO2 (233.1416)


   
   
   

Dexmethylphenidate

methyl (2R)-2-phenyl-2-[(2R)-piperidin-2-yl]acetate

C14H19NO2 (233.1416)


N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators

   

Lys-ser

6-amino-2-(2-amino-3-hydroxypropanamido)hexanoic acid

C9H19N3O4 (233.1375)


A dipeptide formed from L-lysine and L-serine residues.

   

Ser-lys

2-(2,6-diaminohexanamido)-3-hydroxypropanoic acid

C9H19N3O4 (233.1375)


A dipeptide composed of L-serine and L-lysine joined by a peptide linkage. It is a constituent of bacterial cell wall peptidoglycan type A11.14 and A3alpha.

   

Lysinoalanine

2-amino-6-[(2-amino-2-carboxyethyl)amino]hexanoic acid

C9H19N3O4 (233.1375)


   

Thalictroidine

1-(4-hydroxyphenyl)-2-(1-methylpiperidin-2-yl)ethan-1-one

C14H19NO2 (233.1416)


   

CAR 3:0;O

(3S)-3-[(3-hydroxypropanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C10H19NO5 (233.1263)


   

(4aS,11bS)-9-methoxy-2,3,4,4a,5,6,7,11b-octahydrobenzo[1,2]cyclohepta[4,6-c][1,4]oxazine

(4aS,11bS)-9-methoxy-2,3,4,4a,5,6,7,11b-octahydrobenzo[1,2]cyclohepta[4,6-c][1,4]oxazine

C14H19NO2 (233.1416)


   

Ethyl 1-benzylpyrrolidine-3-carboxylate

Ethyl 1-benzylpyrrolidine-3-carboxylate

C14H19NO2 (233.1416)


   

4-Phenyl-3-piperidinecarboxylic acid ethyl ester

4-Phenyl-3-piperidinecarboxylic acid ethyl ester

C14H19NO2 (233.1416)


   

2-amino-2-cyclohexyl-2-phenylacetic acid

2-amino-2-cyclohexyl-2-phenylacetic acid

C14H19NO2 (233.1416)


   

Methyl 2-(1-piperidinylmethyl)benzoate

Methyl 2-(1-piperidinylmethyl)benzoate

C14H19NO2 (233.1416)


   

1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid t-butyl ester

1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid t-butyl ester

C14H19NO2 (233.1416)


   

(S)-METHYL 2-((TERT-BUTOXYCARBONYL)AMINO)-3-METHOXYPROPANOATE

(S)-METHYL 2-((TERT-BUTOXYCARBONYL)AMINO)-3-METHOXYPROPANOATE

C10H19NO5 (233.1263)


   

1-M-TOLYLAMINOCYCLOHEXANECARBOXYLICACID

1-M-TOLYLAMINOCYCLOHEXANECARBOXYLICACID

C14H19NO2 (233.1416)


   

1-BENZYL-4-PIPERIDINEACETIC ACID

1-BENZYL-4-PIPERIDINEACETIC ACID

C14H19NO2 (233.1416)


   

5-TERT-BUTYL-2-(2-FLUORO-PHENYL)-2H-PYRAZOL-3-YLAMINE

5-TERT-BUTYL-2-(2-FLUORO-PHENYL)-2H-PYRAZOL-3-YLAMINE

C13H16FN3 (233.1328)


   

3-Methyl-1-(phenylmethyl)-3-pyrrolidinecarboxylic acid methyl ester

3-Methyl-1-(phenylmethyl)-3-pyrrolidinecarboxylic acid methyl ester

C14H19NO2 (233.1416)


   

Methyl 1-benzylpiperidine-4-carboxylate

Methyl 1-benzylpiperidine-4-carboxylate

C14H19NO2 (233.1416)


   

methyl (2S)-4-hydroxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoate

methyl (2S)-4-hydroxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoate

C10H19NO5 (233.1263)


   

7-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid

7-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid

C14H19NO2 (233.1416)


   

1-O-TOLYLAMINOCYCLOHEXANECARBOXYLICACID

1-O-TOLYLAMINOCYCLOHEXANECARBOXYLICACID

C14H19NO2 (233.1416)


   

N-(2-HYDROXY-CYCLOHEXYL)-N-METHYL-BENZAMIDE

N-(2-HYDROXY-CYCLOHEXYL)-N-METHYL-BENZAMIDE

C14H19NO2 (233.1416)


   
   

Ethyl 4-phenyl-3-piperidinecarboxylate

Ethyl 4-phenyl-3-piperidinecarboxylate

C14H19NO2 (233.1416)


   

1H-INDAZOLE, 6-FLUORO-3-(1-METHYL-4-PIPERIDINYL)-

1H-INDAZOLE, 6-FLUORO-3-(1-METHYL-4-PIPERIDINYL)-

C13H16FN3 (233.1328)


   

4-[2-(1-Piperidinyl)ethoxy]benzaldehyde

4-[2-(1-Piperidinyl)ethoxy]benzaldehyde

C14H19NO2 (233.1416)


   

Ethyl 1-benzyl-D-prolinate

Ethyl 1-benzyl-D-prolinate

C14H19NO2 (233.1416)


   

(+)-1-DEOXYNOJIRIMYCINHYDROCHLORIDE

(+)-1-DEOXYNOJIRIMYCINHYDROCHLORIDE

C14H19NO2 (233.1416)


   

1,3-Benzodioxole-5-methanamine,N-cyclohexyl-, hydrochloride (1:1)

1,3-Benzodioxole-5-methanamine,N-cyclohexyl-, hydrochloride (1:1)

C14H19NO2 (233.1416)


   

ethyl 6-phenylpiperidine-2-carboxylate

ethyl 6-phenylpiperidine-2-carboxylate

C14H19NO2 (233.1416)


   

ethyl 1-phenylpiperidine-4-carboxylate

ethyl 1-phenylpiperidine-4-carboxylate

C14H19NO2 (233.1416)


   

1-[(3-methylphenyl)methyl]piperidine-4-carboxylic acid

1-[(3-methylphenyl)methyl]piperidine-4-carboxylic acid

C14H19NO2 (233.1416)


   

6-[2-(dimethylamino)ethoxy]-3,4-dihydro-2H-naphthalen-1-one

6-[2-(dimethylamino)ethoxy]-3,4-dihydro-2H-naphthalen-1-one

C14H19NO2 (233.1416)


   

boc-n-me-thr-oh

boc-n-me-thr-oh

C10H19NO5 (233.1263)


   

Boc-Thr(Me)-OH

Boc-Thr(Me)-OH

C10H19NO5 (233.1263)


   

2,2,5,5-tetramethyl-4-phenyl-3-imidazoline-3-oxide-1-oxyl

2,2,5,5-tetramethyl-4-phenyl-3-imidazoline-3-oxide-1-oxyl

C13H17N2O2 (233.129)


   

METHYL1-BENZYL-PIPERIDINE-2-CARBOXYLATE

METHYL1-BENZYL-PIPERIDINE-2-CARBOXYLATE

C14H19NO2 (233.1416)


   

1-Boc-4-Fluoro-4-(hydroxymethyl)piperidine

1-Boc-4-Fluoro-4-(hydroxymethyl)piperidine

C11H20FNO3 (233.1427)


   

(R)-ETHYL 2-((TERT-BUTOXYCARBONYL)AMINO)-3-HYDROXYPROPANOATE

(R)-ETHYL 2-((TERT-BUTOXYCARBONYL)AMINO)-3-HYDROXYPROPANOATE

C10H19NO5 (233.1263)


   

2-Nitro-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene

2-Nitro-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene

C14H19NO2 (233.1416)


   

Piperoxan

1-(2,3-Dihydro-1,4-benzodioxin-2-ylmethyl)piperidine

C14H19NO2 (233.1416)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

   

green carboxylate

green carboxylate

C14H19NO2 (233.1416)


   

1-P-TOLYLAMINOCYCLOHEXANECARBOXYLICACID

1-P-TOLYLAMINOCYCLOHEXANECARBOXYLICACID

C14H19NO2 (233.1416)


   

3-(TERT-BUTYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOL-5-AMINE

3-(TERT-BUTYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOL-5-AMINE

C13H16FN3 (233.1328)


   

n-boc-(r)-2-amino-3-hydroxy-3-methylbutanoic acid

n-boc-(r)-2-amino-3-hydroxy-3-methylbutanoic acid

C10H19NO5 (233.1263)


   

(2S)-2-(N-tert-Butoxycarbonyl)amino-3-hydroxy-3-methylbutanoic acid

(2S)-2-(N-tert-Butoxycarbonyl)amino-3-hydroxy-3-methylbutanoic acid

C10H19NO5 (233.1263)


   

1-(4-hydroxy-3-piperidin-1-ylmethyl-phenyl)-ethanone

1-(4-hydroxy-3-piperidin-1-ylmethyl-phenyl)-ethanone

C14H19NO2 (233.1416)


   

4-(4,4-Dimethylpiperidin-1-yl)benzoic acid

4-(4,4-Dimethylpiperidin-1-yl)benzoic acid

C14H19NO2 (233.1416)


   

(4-(1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL)METHANAMINE

(4-(1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL)METHANAMINE

C11H15N5O (233.1277)


   

5-fluoro-1-methyl-3-piperidin-4-ylindazole

5-fluoro-1-methyl-3-piperidin-4-ylindazole

C13H16FN3 (233.1328)


   

(1R,5S,9r)-7-benzyl-3-oxa-7-azabicyclo[3.3.1]nonan-9-ol

(1R,5S,9r)-7-benzyl-3-oxa-7-azabicyclo[3.3.1]nonan-9-ol

C14H19NO2 (233.1416)


   

1-(1-PYRROLIDINYLCARBONYLMETHYL)PIPERAZINEHYDROCHLORIDE

1-(1-PYRROLIDINYLCARBONYLMETHYL)PIPERAZINEHYDROCHLORIDE

C10H20ClN3O (233.1295)


   

Cyclopropanamine, 1-[3-(1,3-dioxepan-5-yl)phenyl]

Cyclopropanamine, 1-[3-(1,3-dioxepan-5-yl)phenyl]

C14H19NO2 (233.1416)


   

Benzoic acid, 3-(1-aminocyclopropyl)-, 1,1-dimethylethyl ester

Benzoic acid, 3-(1-aminocyclopropyl)-, 1,1-dimethylethyl ester

C14H19NO2 (233.1416)


   

1-Benzyl-2-piperidineacetic Acid

1-Benzyl-2-piperidineacetic Acid

C14H19NO2 (233.1416)


   

methyl (3R,4R)-1-benzyl-4-methylpyrrolidine-3-carboxylate

methyl (3R,4R)-1-benzyl-4-methylpyrrolidine-3-carboxylate

C14H19NO2 (233.1416)


   

benzyl (2R)-1,2-dimethylpyrrolidine-2-carboxylate

benzyl (2R)-1,2-dimethylpyrrolidine-2-carboxylate

C14H19NO2 (233.1416)


   

1-(2-METHYLBENZYL)PIPERIDINE-4-CARBOXYLIC ACID

1-(2-METHYLBENZYL)PIPERIDINE-4-CARBOXYLIC ACID

C14H19NO2 (233.1416)


   

2-((TERT-BUTOXYCARBONYL)AMINO)-3-HYDROXY-3-METHYLBUTANOIC ACID

2-((TERT-BUTOXYCARBONYL)AMINO)-3-HYDROXY-3-METHYLBUTANOIC ACID

C10H19NO5 (233.1263)


   

n-benzyl-l-proline ethyl ester

n-benzyl-l-proline ethyl ester

C14H19NO2 (233.1416)


   

hexahydro-3-(3-methoxyphenyl)-1-methyl-2H-azepin-2-one

hexahydro-3-(3-methoxyphenyl)-1-methyl-2H-azepin-2-one

C14H19NO2 (233.1416)


   

4-[(4-Methyl-1-piperidinyl)methyl]benzoic acid

4-[(4-Methyl-1-piperidinyl)methyl]benzoic acid

C14H19NO2 (233.1416)


   

4-(HEPTYLOXY)PHENYL ISOCYANATE

4-(HEPTYLOXY)PHENYL ISOCYANATE

C14H19NO2 (233.1416)


   

N-(4-phenylbutan-2-yl) 3-oxobutanamide

N-(4-phenylbutan-2-yl) 3-oxobutanamide

C14H19NO2 (233.1416)


   

(S)-N-BOC-2-AMINO-3-ETHOXY-PROPIONIC ACID

(S)-N-BOC-2-AMINO-3-ETHOXY-PROPIONIC ACID

C10H19NO5 (233.1263)


   

N,O-Di-Boc-hydroxylamine

N,O-Di-Boc-hydroxylamine

C10H19NO5 (233.1263)


   

Methyl 1-benzyl-4-methylpyrrolidine-3-carboxylate

Methyl 1-benzyl-4-methylpyrrolidine-3-carboxylate

C14H19NO2 (233.1416)


   

ethyl 3-hydroxy-4,4-dimethoxypiperidine-1-carboxylate

ethyl 3-hydroxy-4,4-dimethoxypiperidine-1-carboxylate

C10H19NO5 (233.1263)


   

3-oxooctanoic acid glyceride

3-oxooctanoic acid glyceride

C11H21O5- (233.1389)


   

1-morpholin-4-yl-4-phenyl-butan-1-one

1-morpholin-4-yl-4-phenyl-butan-1-one

C14H19NO2 (233.1416)


   

N-(tert-Butoxycarbonyl)-L-threonine methyl ester

N-(tert-Butoxycarbonyl)-L-threonine methyl ester

C10H19NO5 (233.1263)


   

6-AMINO-5-(TERT-BUTYL)-3,3-DIMETHYLBENZOFURAN-2(3H)-ONE

6-AMINO-5-(TERT-BUTYL)-3,3-DIMETHYLBENZOFURAN-2(3H)-ONE

C14H19NO2 (233.1416)


   

(Z)-but-2-enedioic acid,2-(dimethylamino)-2-methylpropan-1-ol

(Z)-but-2-enedioic acid,2-(dimethylamino)-2-methylpropan-1-ol

C10H19NO5 (233.1263)


   
   

Methyl 3-(piperidin-1-ylmethyl)benzoate

Methyl 3-(piperidin-1-ylmethyl)benzoate

C14H19NO2 (233.1416)


   

(R)-1-(4-METHYLPHENYL)ETHYLAMINE

(R)-1-(4-METHYLPHENYL)ETHYLAMINE

C14H19NO2 (233.1416)


   

6-(tert-Butyl)-2,2-dimethyl-2H-benzo[b][1,4]oxazin-3(4H)-one

6-(tert-Butyl)-2,2-dimethyl-2H-benzo[b][1,4]oxazin-3(4H)-one

C14H19NO2 (233.1416)


   

tert-Butyl (2-phenylcyclopropyl)carbamate

tert-Butyl (2-phenylcyclopropyl)carbamate

C14H19NO2 (233.1416)


   

Levofacetoperane

Levophacetoperane

C14H19NO2 (233.1416)


C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant

   

1-(2-METHYLBENZYL)PIPERIDINE-3-CARBOXYLIC ACID

1-(2-METHYLBENZYL)PIPERIDINE-3-CARBOXYLIC ACID

C14H19NO2 (233.1416)


   

(3S,4R)-rel-1-Boc-3-fluoro-4-(hydroxyMethyl)piperidine

(3S,4R)-rel-1-Boc-3-fluoro-4-(hydroxyMethyl)piperidine

C11H20FNO3 (233.1427)


   

methyl-1-benzylpiperidine-3-carboxylate

methyl-1-benzylpiperidine-3-carboxylate

C14H19NO2 (233.1416)


   

Methyl N-{[(2-methyl-2-propanyl)oxy]carbonyl}homoserinate

Methyl N-{[(2-methyl-2-propanyl)oxy]carbonyl}homoserinate

C10H19NO5 (233.1263)


   

6-fluoro-1-methyl-3-piperidin-4-ylindazole

6-fluoro-1-methyl-3-piperidin-4-ylindazole

C13H16FN3 (233.1328)


   

1-(3,4-DIMETHYLPHENYLAMINO)CYCLOPENTANECARBOXYLICACID

1-(3,4-DIMETHYLPHENYLAMINO)CYCLOPENTANECARBOXYLICACID

C14H19NO2 (233.1416)


   

1-(3,5-DIMETHYLPHENYLAMINO)CYCLOPENTANECARBOXYLICACID

1-(3,5-DIMETHYLPHENYLAMINO)CYCLOPENTANECARBOXYLICACID

C14H19NO2 (233.1416)


   

1-[(2S)-2-(benzyloxy)propanoyl]pyrrolidine

1-[(2S)-2-(benzyloxy)propanoyl]pyrrolidine

C14H19NO2 (233.1416)


   

N-BOC-ALPHA-METHYL-D-SERINE METHYL ESTER

N-BOC-ALPHA-METHYL-D-SERINE METHYL ESTER

C10H19NO5 (233.1263)


   

METHYL 3-PHENYL-3-(PYRROLIDIN-1-YL)PROPANOATE

METHYL 3-PHENYL-3-(PYRROLIDIN-1-YL)PROPANOATE

C14H19NO2 (233.1416)


   

methyl 4-(piperidin-1-ylmethyl)benzoate

methyl 4-(piperidin-1-ylmethyl)benzoate

C14H19NO2 (233.1416)


   

1-METHYL-6,7-DIETHOXY-3,4-DIHYDROISOQUINOLINE

1-METHYL-6,7-DIETHOXY-3,4-DIHYDROISOQUINOLINE

C14H19NO2 (233.1416)


   

Hopantenic acid

Hopantenic acid

C10H19NO5 (233.1263)


D002491 - Central Nervous System Agents > D018697 - Nootropic Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent

   

Norketobemidone

Norketobemidone

C14H19NO2 (233.1416)


   

Daytrana

Daytrana

C14H19NO2 (233.1416)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators

   

Methoxmetamine

Methoxmetamine

C14H19NO2 (233.1416)


   

L-Lysine, N6-(2-amino-2-carboxyethyl)-

L-Lysine, N6-(2-amino-2-carboxyethyl)-

C9H19N3O4 (233.1375)


   

methyl (S)-phenyl[(R)-piperidin-2-yl]acetate

methyl (S)-phenyl[(R)-piperidin-2-yl]acetate

C14H19NO2 (233.1416)


   

methyl (R)-phenyl[(S)-piperidin-2-yl]acetate

methyl (R)-phenyl[(S)-piperidin-2-yl]acetate

C14H19NO2 (233.1416)


   

L-Lysine, N6-(2-amino-2-carboxyethyl)-, (R)-

L-Lysine, N6-(2-amino-2-carboxyethyl)-, (R)-

C9H19N3O4 (233.1375)


   

Lysinoalanine, (S,S)-

Lysinoalanine, (S,S)-

C9H19N3O4 (233.1375)


   

2-(2,6-Diaminohexanoylamino)-3-hydroxypropanoic acid

2-(2,6-Diaminohexanoylamino)-3-hydroxypropanoic acid

C9H19N3O4 (233.1375)


   

2-[[(2S)-2,6-diaminohexanoyl]amino]oxypropanoic acid

2-[[(2S)-2,6-diaminohexanoyl]amino]oxypropanoic acid

C9H19N3O4 (233.1375)


   

5-(2-Cyclohexylethyl)-2-pyridinecarboxylic acid

5-(2-Cyclohexylethyl)-2-pyridinecarboxylic acid

C14H19NO2 (233.1416)


   

Hydroxypropionylcarnitine

Hydroxypropionylcarnitine

C10H19NO5 (233.1263)


   
   

O-(hydroxypropionyl)carnitine

O-(hydroxypropionyl)carnitine

C10H19NO5 (233.1263)


An O-acylcarnitine in which the acyl group specified is hydroxypropionyl.

   

O-hydroxypropionyl-L-carnitine

O-hydroxypropionyl-L-carnitine

C10H19NO5 (233.1263)


An O-acyl-L-carnitine in which the acyl group specified is hydroxypropionyl in which the position of the hydroxy group is unspecified..

   

Ethyl 4-phenylpiperidine-4-carboxylate

Ethyl 4-phenylpiperidine-4-carboxylate

C14H19NO2 (233.1416)


   
   
   

Fluoroethylnormemantine (hydrochloride)

Fluoroethylnormemantine (hydrochloride)

C12H21ClFN (233.1346)


Fluoroethylnormemantine hydrochloride, a derivative of Memantine, is an antagonist of the N-methyl-D-aspartate (NMDA) receptor. [18F]-Fluoroethylnormemantine hydrochloride can be used as a positron emission tomography (PET) tracer. Fluoroethylnormemantine hydrochloride exhibits anti-amnesic, neuroprotective, antidepressant-like and fear-attenuating effects[1][2][3].

   

4-[2-(methylamino)ethyl]-2-[(1z)-2-[(2r)-2-methyloxiran-2-yl]ethenyl]phenol

4-[2-(methylamino)ethyl]-2-[(1z)-2-[(2r)-2-methyloxiran-2-yl]ethenyl]phenol

C14H19NO2 (233.1416)


   

(2s)-4-(1-methoxyindol-3-yl)-2-methylbutan-1-ol

(2s)-4-(1-methoxyindol-3-yl)-2-methylbutan-1-ol

C14H19NO2 (233.1416)


   

4-(1-methoxyindol-3-yl)-2-methylbutan-1-ol

4-(1-methoxyindol-3-yl)-2-methylbutan-1-ol

C14H19NO2 (233.1416)


   

(e)-methoxy(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethylidene)amine

(e)-methoxy(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethylidene)amine

C14H19NO2 (233.1416)


   

8,9-dimethoxy-1h,2h,3h,5h,6h,10bh-pyrrolo[2,1-a]isoquinoline

8,9-dimethoxy-1h,2h,3h,5h,6h,10bh-pyrrolo[2,1-a]isoquinoline

C14H19NO2 (233.1416)


   

n-[2-(4-methoxyphenyl)ethyl]-2-methylbut-2-enimidic acid

n-[2-(4-methoxyphenyl)ethyl]-2-methylbut-2-enimidic acid

C14H19NO2 (233.1416)


   

2-methyl-4-(9h-purin-6-ylamino)pent-2-en-1-ol

2-methyl-4-(9h-purin-6-ylamino)pent-2-en-1-ol

C11H15N5O (233.1277)


   

(2e,4r)-2-methyl-4-(9h-purin-6-ylamino)pent-2-en-1-ol

(2e,4r)-2-methyl-4-(9h-purin-6-ylamino)pent-2-en-1-ol

C11H15N5O (233.1277)


   

methyl (5r,8s)-2,5-dimethyl-5h,6h,7h,8h,9h-cyclohepta[b]pyridine-8-carboxylate

methyl (5r,8s)-2,5-dimethyl-5h,6h,7h,8h,9h-cyclohepta[b]pyridine-8-carboxylate

C14H19NO2 (233.1416)


   

(2r)-4-(1-methoxyindol-3-yl)-2-methylbutan-1-ol

(2r)-4-(1-methoxyindol-3-yl)-2-methylbutan-1-ol

C14H19NO2 (233.1416)


   

methoxy(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethylidene)amine

methoxy(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethylidene)amine

C14H19NO2 (233.1416)


   

(2e)-2-methyl-4-(9h-purin-6-ylamino)pent-2-en-1-ol

(2e)-2-methyl-4-(9h-purin-6-ylamino)pent-2-en-1-ol

C11H15N5O (233.1277)


   

1-[(5s,8s)-2,5-dimethyl-5h,6h,7h,8h,9h-cyclohepta[b]pyridin-8-yl]-2-hydroxyethanone

1-[(5s,8s)-2,5-dimethyl-5h,6h,7h,8h,9h-cyclohepta[b]pyridin-8-yl]-2-hydroxyethanone

C14H19NO2 (233.1416)


   

(z)-methoxy(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethylidene)amine

(z)-methoxy(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethylidene)amine

C14H19NO2 (233.1416)


   

(2e)-n-[2-(4-methoxyphenyl)ethyl]-2-methylbut-2-enimidic acid

(2e)-n-[2-(4-methoxyphenyl)ethyl]-2-methylbut-2-enimidic acid

C14H19NO2 (233.1416)


   

4-[2-(methylamino)ethyl]-2-[2-(2-methyloxiran-2-yl)ethenyl]phenol

4-[2-(methylamino)ethyl]-2-[2-(2-methyloxiran-2-yl)ethenyl]phenol

C14H19NO2 (233.1416)


   

(10br)-8,9-dimethoxy-1h,2h,3h,5h,6h,10bh-pyrrolo[2,1-a]isoquinoline

(10br)-8,9-dimethoxy-1h,2h,3h,5h,6h,10bh-pyrrolo[2,1-a]isoquinoline

C14H19NO2 (233.1416)